Target intelligence / Profile preview

Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP)

Target
VE-PTP
Molecular classification
Receptor-type protein tyrosine phosphatase, Transmembrane receptor
01

Overview

Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP) is a receptor-type protein tyrosine phosphatase predominantly expressed in vascular endothelial cells. It plays a crucial role in regulating angiogenesis, vascular permeability, and the integrity of endothelial cell junctions. VE-PTP acts by dephosphorylating key substrates like VE-cadherin and Tie2, influencing cell adhesion, signaling pathways, and vascular remodeling. Dysregulation of VE-PTP is implicated in various diseases, including cancer and inflammatory conditions, making it a potential therapeutic target for modulating angiogenesis and vascular function.

Other names
PTPRBProtein Tyrosine Phosphatase, Receptor Type B
02

Mechanism of action

Dephosphorylates tyrosine residues on target proteins, such as VE-cadherin and Tie2, to regulate their activity and downstream signaling pathways.

03

Biological functions

Angiogenesis regulationVascular developmentVascular homeostasisRegulation of endothelial junctionsCell adhesionVascular permeability regulation
04

Disease associations

CancerInflammationVascular permeability disordersTumor angiogenesisVasculogenic mimicry
05

Safety considerations

Modulating VE-PTP activity can have complex effects on vascular stability and permeability, requiring careful titration to avoid adverse effects.Potential for off-target effects due to the broad substrate specificity of phosphatases.Disrupting normal angiogenesis during development may cause embryonic lethality.

Beyond the preview

Go deeper on Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call